Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PULSE BIOSCIENCES, INC. shareholders approved Election of seven directors to hold office until the Company’s 2027 annual meeting and until their successors are duly elected and qualified at the 2026-06-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
1. Election of Directors Nominee For Against Abstained Broker Non-votes Robert W. Duggan 33,443,582 1,583,174 388 10,974,550 Paul A. LaViolette 34,264,295 759,401 3,448 10,974,550 Maria Sainz 35,007,101 18,349 1,694 10,974,550 Manmeet S. Soni 33,560,875 1,464,574 1,695 10,974,550 Darrin R. Uecker 34,246,413 779,036 1,695 10,974,550 Richard A. van den Broek 34,278,978 746,471 1,695 10,974,550 Mahkam Zanganeh, D.D.S. 34,241,938 783,511 1,695 10,974,550 Each director nominee was duly elected
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PULSE BIOSCIENCES, INC. shareholders approved Ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstained Broker Non-votes 45,976,355 8,265 17,074 N/A The stockholders ratified the appointment of Deloitte & Touche LLP
View on SEC.gov